Company description

Fresenius Kabi Austria is a subsidiary of the global healthcare group Fresenius. The Linz plant is the competence center for manufacturing the APIs Lactulose and Hydroxyethyl starch (HES). With 40 years of expertise in Lactulose production, highest quality standards and a second Lactulose plant in Italy, we rank among the leading global Lactulose producers. We supply liquid and crystalline Lactulose, as bulk or finished product in various containers and sachets, filled and packed on-site. Our plant also houses the world's largest production of HES, which is mainly used in volume therapy. Our plant is cGMP- and ISO-certified.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Other APIs |Out-licensing |Sprays More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 4H52, 14F10 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 60C31 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with FRESENIUS KABI AUSTRIA


Contact information




View all contact information